{"id":"W3022456477","doi":"10.1016/j.msard.2020.102086","title":"Alemtuzumab and prescription medication use in the MS population","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Marshall-Smith Syndroom Research Foundation; Multiple Sclerosis International Federation; Stichting MS Research; American Academy of Neurology; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Canada Foundation for Innovation; National Multiple Sclerosis Society","keywords":"Alemtuzumab; Medicine; Medical prescription; Polypharmacy; Multiple sclerosis; Population; Drug; Adverse effect; Pediatrics; Internal medicine; Psychiatry; Pharmacology; Environmental health","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003024998,0.0001557016,0.0002259294,0.00009609308,0.0001959688,0.00006503793,0.00006908393,0.000130743,0.00002860153],"category_scores_gemma":[0.001061703,0.0001048411,0.00004951868,0.0003134817,0.0001715107,0.0002451618,0.00006673951,0.0003278729,0.00000597616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003155174,"about_ca_system_score_gemma":0.00001263682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001508985,"about_ca_topic_score_gemma":0.0005947544,"domain_scores_codex":[0.9985633,0.0001523745,0.0003208978,0.0003623238,0.0003629131,0.0002381879],"domain_scores_gemma":[0.9993507,0.0002295142,0.0000751301,0.0001685794,0.00003686149,0.0001391608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002940055,0.0001665299,0.9189225,0.0001251086,0.00008503855,0.000001921897,0.006648956,0.00008739255,0.007407284,0.00009719702,0.00115526,0.06500883],"study_design_scores_gemma":[0.003385325,0.0001502992,0.968415,0.0001199348,0.00004357015,0.000002562144,0.001105753,0.02548436,0.00002424162,0.00004455998,0.001113523,0.0001109152],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819104,0.001406494,0.00004948429,0.01530249,0.00005134179,0.0009434761,0.000009648731,0.00005746974,0.0002691793],"genre_scores_gemma":[0.9890098,0.01004962,0.0001763084,0.0005351836,0.00003272646,0.00006655064,0.00008825323,0.0000175061,0.000024067],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06489792,"threshold_uncertainty_score":0.4275295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06380809541472414,"score_gpt":0.2727158265422622,"score_spread":0.208907731127538,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}